| scholarly article | Q13442814 |
| P2093 | author name string | Julia Bielicki | |
| Laura Folgori | |||
| P2860 | cites work | Extended-spectrum beta-lactamases: a clinical update | Q24534999 |
| Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae | Q24628782 | ||
| Updated functional classification of beta-lactamases | Q24644798 | ||
| Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis | Q27002495 | ||
| Treating infections caused by carbapenemase-producing Enterobacteriaceae | Q27011304 | ||
| Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections | Q28082546 | ||
| Aetiology of community-acquired neonatal sepsis in low and middle income countries | Q28714316 | ||
| Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. | Q30580647 | ||
| Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring | Q30654297 | ||
| EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study | Q33552772 | ||
| High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania | Q33825017 | ||
| Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome | Q34106854 | ||
| Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention | Q34190800 | ||
| The structure of β-lactamases | Q34246186 | ||
| Carbapenem-resistant enterobacteriaceae: an emerging problem in children | Q34281727 | ||
| International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics | Q34382371 | ||
| Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management | Q34437229 | ||
| Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study. | Q34494960 | ||
| Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. | Q34496803 | ||
| A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1. | Q34535379 | ||
| Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial | Q35193312 | ||
| Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat | Q35555196 | ||
| Global spread of Carbapenemase-producing Enterobacteriaceae | Q35847641 | ||
| Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens | Q35867414 | ||
| Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China | Q35908410 | ||
| "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio | Q36115511 | ||
| Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. | Q36212092 | ||
| The Ethical Significance of Antimicrobial Resistance | Q36263119 | ||
| Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability | Q36263480 | ||
| Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases | Q36357629 | ||
| Carbapenem-Resistant Enterobacteriaceae Infections in Children | Q37154718 | ||
| Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience | Q37346289 | ||
| A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates | Q37899151 | ||
| Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe | Q38002952 | ||
| Continuous infusion of antibiotics in critically ill patients | Q38040471 | ||
| Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. | Q38117505 | ||
| Treatment of multidrug-resistant Gram-negative infections in children | Q38185648 | ||
| Deaths attributable to carbapenem-resistant Enterobacteriaceae infections | Q38222776 | ||
| The contribution of extended-spectrum β-lactamases to multidrug-resistant infections in children | Q38309954 | ||
| Pediatric sepsis in the developing world | Q38445447 | ||
| Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study | Q38477582 | ||
| Sepsis in children | Q38523197 | ||
| Outbreaks of extended spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units: a systematic review. | Q38586596 | ||
| Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries | Q38592904 | ||
| The Relationship between Gram-Negative Colonisation and Bloodstream Infections in Neonates: A Systematic Review and Meta-Analysis | Q38613455 | ||
| Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management | Q38615334 | ||
| Access to effective antimicrobials: a worldwide challenge | Q38646928 | ||
| The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect? | Q38892589 | ||
| Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment | Q38901121 | ||
| Multidrug efflux pumps of Gram-positive bacteria | Q38905982 | ||
| Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis | Q39119101 | ||
| Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases | Q39610632 | ||
| Extended-Spectrum β-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Children: Trends in the United States, 1999-2011. | Q40254371 | ||
| Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children | Q40346594 | ||
| Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children | Q40433501 | ||
| Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities. | Q40833650 | ||
| Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Infections in Children: A Two-Center Case-Case-Control Study of Risk Factors and Outcomes in Chicago, Illinois. | Q40887559 | ||
| Lack of new antiinfective agents: Passing into the pre-antibiotic age? | Q41024475 | ||
| Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae | Q41042616 | ||
| The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. | Q41990527 | ||
| Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. | Q42577452 | ||
| Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit | Q44563016 | ||
| Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital. | Q45381450 | ||
| Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms | Q50022002 | ||
| Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. | Q54456881 | ||
| Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit | Q80239976 | ||
| P433 | issue | 1 | |
| P921 | main subject | emerging pathogen | Q108429945 |
| P304 | page(s) | 17-24 | |
| P577 | publication date | 2019-01-17 | |
| P1433 | published in | Journal of pediatric intensive care | Q27724905 |
| P1476 | title | Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance | |
| P478 | volume | 8 |
Search more.